Key result
Cardiac resynchronization therapy improves survival and reduces hospitalizations in symptomatic heart failure patients with reduced ejection fraction and wide QRS, though it remains largely underused.
Why the study?
Despite proven benefits in symptomatic HFrEF with wide QRS, CRT remains largely underused, with national variations, evidence gaps, and implementation obstacles.
Does cardiac resynchronization therapy improve outcomes in patients with heart failure with reduced ejection fraction?
Does cardiac resynchronization therapy improve outcomes in patients with heart failure with reduced ejection fraction?
This review highlights the underutilization of CRT in eligible HFrEF patients and emphasizes the need for personalized medicine approaches considering sex and body size.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Cecilia Linde (2023) conducted a review in Heart failure with reduced ejection fraction. Cardiac resynchronization therapy (CRT) was evaluated. Cardiac resynchronization therapy improves survival and reduces hospitalizations in symptomatic heart failure patients with reduced ejection fraction and wide QRS, though it remains largely underused.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: